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Abstract Polymorphisms (SNPs) within the FADS gene
cluster and the ELOVL gene family are believed to influence
enzyme activities after an omega-3 (n-3) fatty acid (FA)
supplementation. The objectives of the study are to test
whether an n-3 supplementation is associated with indexes
of desaturase and elongase activities in addition to verify
whether SNPs in the FADS gene cluster and the ELOVL
gene family modulate enzyme activities of desaturases and
elongases. A total 208 subjects completed a 6-week sup-
plementation period with 5 g/day of fish oil (1.9–2.2 g/day
of EPA ? 1.1 g/day of DHA). FA profiles of plasma
phospholipids were obtained by gas chromatography
(n = 210). Desaturase and elongase indexes were estimated
using product-to-precursor ratios. Twenty-eight SNPs from
FADS1, FADS2, FADS3, ELOVL2 and ELOVL5 were
genotyped using TaqMan technology. Desaturase indexes
were significantly different after the 6-week n-3 supple-
mentation. The index of d-5 desaturase activity increased by
25.7 ± 28.8 % (p \ 0.0001), whereas the index of d-6
desaturase activity decreased by 17.7 ± 18.2 %
(p \ 0.0001) post-supplementation. Index of elongase
activity decreased by 39.5 ± 27.9 % (p \ 0.0001). Some
gene–diet interactions potentially modulating the enzyme
activities of desaturases and elongases involved in the FA
metabolism post-supplementation were found. SNPs within
the FADS gene cluster and the ELOVL gene family may
play an important role in the enzyme activity of desaturases
and elongases, suggesting that an n-3 FAs supplementation
may affect PUFA metabolism.
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Elongation and desaturation of long-chain (LC) polyun-
saturated fatty acids (PUFA) of the omega-3 (n-3) family
are made possible by enzymes called desaturases and
elongases. Figure 1 shows the metabolic pathway of n-3
and omega-6 (n-6) fatty acids (FA) with an emphasis on
enzymes required for synthesis of LC-PUFAs. The use of
the d-6 desaturases (D6D) twice in the conversion of alpha-
linolenic acid (ALA) to docosahexaenoic acid (DHA)
suggests that this enzyme may play a key regulatory role in
the PUFA metabolism (Portolesi et al. 2007).
Fatty acid desaturase 1 and 2 (FADS1 and FADS2,
respectively) genes encode for key enzymes in the PUFA
metabolism, the d-5 desaturase (D5D) and D6D, respec-
tively (Malerba et al. 2008). These desaturases are
responsible for the double bond formation between two
carbons leading to more unsaturated FAs. Elongases are
encoded by genes within the ELOVL family and catalyzes
the elongation of the aliphatic chain of carbons leading to
the formation of LC-PUFAs (Jakobsson et al. 2006). Two
elongases are involved in LC-PUFA synthesis, the fatty
acid elongase-2 and the fatty acid elongase-5, encoded,
respectively, by ELOVL2 and ELOVL5 genes. A high
desaturase activity may lead to an increased bioavailability
of arachidonic acid (AA) with dominant synthesis of AA-
derived proinflammatory eicosanoids, possibly leading to
vascular damage, especially in populations eating a Wes-
tern diet (Martinelli et al. 2009). Excessive amounts of n-6
FAs from the diet and from the endogenous synthesis, as
seen in today’s Western diets, promote the pathogenesis of
many diseases including cardiovascular disease, cancers as
well as inflammatory and autoimmune diseases, whereas
increased levels of n-3 FA (a lower n-6/n-3 ratio) exert
suppressive effects (Simopoulos 2008). In opposition to a
diet rich in n-6 PUFA, a diet rich in n-3 FAs could result in
a preferential synthesis of anti-inflammatory eicosanoids in
addition to a high desaturase activity (Martinelli et al.
2009). A shift from n-6 to n-3 induces changes in the
eicosanoid profile, which may lead to a decrease inflam-
matory state (Calder 2009).
There is a high affinity of D6D for ALA (D’Andrea
et al. 2002), thus favouring the n-3 FA pathway at the
expense of the n-6 pathway (Sprecher 2002). These two
classes of FAs compete for a number of enzyme systems
which can influence inflammatory responses, vascular
reactivity, and platelet aggregation (Harris 2006). More-
over, oleic acid (18:1n-9) from the omega-9 (n-9) pathway
is also metabolized by D5D and D6D (Das 2007). As a
Fig. 1 Synthesis of n-3 and n-6 PUFAs in humans. Elongases and
desaturases are the enzymes responsible for the conversion of a-
linolenic acid (ALA, C18:3n-3) to eicosapentaenoic acid (EPA,
C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3). They are also
involved in the synthesis of omega-60s products, mainly the
arachidonic acid (AA, C20:4n-6) which leads to the production of
proinflammatory mediators. Desaturases and elongases are both
involved in the fatty acid metabolism. These enzymes are encoded
by genes from the FADS gene cluster and the ELOVL gene family
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result, all these series of FAs, i.e., n-3, n-6, and n-9,
compete for the same set of enzymes, although a prefer-
ential affinity has been demonstrated according to the fol-
lowing sequence: n-3 [ n-6 [ n-9 (Das 2007).
Recent studies suggested that some common SNPs of
the FADS gene cluster and of the ELOVL gene family
(Tanaka et al. 2009) are associated with plasma n-6 and n-3
FA levels. Accordingly, Lemaitre et al. (2011) have shown,
in a genome-wide association studies in five population-
based cohorts comprising 8,866 subjects of European
ancestry, that SNPs from the FADS gene cluster and from
ELOVL2 gene were associated with plasma eicosapentae-
noic acid, DHA and ALA levels measured in plasma
phospholipids. SNPs within the FADS gene cluster, in
particular rs175547, are also believed to alter desaturase
activity in two different ethnic populations, Caucasian and
Asian, as shown by Merino et al. (2011).
The objectives of the present study are to test whether
n-3 FA supplementation is associated with indexes of
desaturase and elongase activities as determined by prod-
uct-to-precursor ratios in addition to verify whether SNPs
in the FADS gene cluster and the ELOVL gene family
modulate enzyme activities of desaturases and elongases
following an n-3 FA supplementation.
Materials and methods
Sociodemographics
Two hundred and fifty-four unrelated subjects from the
greater Quebec City metropolitan area were recruited
between September 2009 and December 2011 through
advertisements in local newspapers as well as by electronic
messages sent to university students/employees. To be
eligible for the study, subjects had to be aged between 18
and 50 years with a body mass index (BMI) between 25
and 40 kg/m2. They had to be non-smokers and free of any
thyroid or metabolic disorders such as hypo/hyperthyroid-
ism, dyslipidemia, and type 2 diabetes among others.
Subjects were excluded if they had taken fish oil supple-
ments for at least 6 months prior to the beginning of the
study and if their baseline triglyceride levels were above
4.0 mmol/l. Statistical analyses were performed on 210
individuals who completed the supplementation period.
Study design
The complete study design has been previously reported
(Cormier et al. 2012). Briefly, subjects followed a run-in
period of 2 weeks where a trained registered dietitian gave
individual dietary instructions. Recommendations were
drawn from the Canada’s Food Guide to Healthy Eating
(Eating Well with Canada’s Food Guide 2007). After a
2-week run-in period, each participant received a bottle
containing n-3 FA capsules (Ocean Nutrition, Nova Scotia,
Canada) covering the following 6-week period. They had
to take five capsules per day, which gave them a total of
3–3.3 g of n-3 FA (1.9–2.2 g EPA and 1.1 g DHA) per
day. Subjects had to report any deviations that may have
occurred during the protocol. They also had to write down
their alcohol and fish consumption on a log sheet. Before
each phase of the study, subjects received written and oral
dietary instructions by a registered dietitian.
SNPs selection and genotyping
SNPs in FADS1, FADS2, FADS3, ELOVL2 and ELOVL5
were identified using the International HapMap Project SNP
database, based on the NCBI B36 assembly Data Rel 28.
phase II ? III, build 126. The FADS gene cluster is made of
three genes that are located very close to each other among
chromosome 11. Because of the head-to-head orientation of
FADS1 and FADS2 and the tail-to-tail orientation of FADS2
and FADS3, we added 500-kilo base pairs (kbp) downstream
of FADS1 and 2,500-kbp upstream of FADS3 to cover the
50UTR and 30UTR regions. Intergenic areas comprised
between FADS1 and FADS2 and between FADS2 and
FADS3 were also covered. ELOVL2 and ELOVL5 genes are
both located on chromosome 6. Gene Tagger procedure in
Haploview V4.2 was used to determine tag SNPs using a
minor allele frequency C1 % and pairwise tagging
(r2 C 0.8). Subsequently, we examined linkage disequilib-
rium out of the nineteen SNPs of the FADS gene cluster area,
the 4 tSNPs of the ELOVL5 gene, and the 6 tSNPs of the
ELOVL2 gene using the LD Plot procedure in Haploview
V4.2. The SIGMA GenElute Gel Extraction Kit (Sigma-
Aldrich Co. St.Louis. Missouri. USA) has been used to
extract genomic DNA. Selected SNPs of the FADS gene
cluster (rs174456, rs174627, rs482548, rs2072114,
rs12807005, rs174448, rs2845573, rs7394871, rs7942717,
rs74823126, rs174602, rs498793, rs7935946, rs174546,
rs174570, rs174579, rs174611, rs174616 and rs968567) and
of the ELOVL genes (rs209492, rs2073040, rs2294852,
rs9370194, rs13204015, rs12195587, rs4532436,
rs3734397, rs2281591 and rs3798710) have been genotyped
using validated primers and TaqMan probes (Life Tech-
nologies Corporation, Burlington, On.) (Livak 1999). DNA
was mixed with TaqMan Universal PCR Master Mix (Life
Technologies Corporation, Burlington, On.), with a gene-
specific primer and with probe mixture (predeveloped
TaqMan SNP Genotyping Assays; Life Technologies Cor-
poration, Burlington, On.) in a final volume of 10 ll.
Genotypes were determined using a 7500 RT-PCR System
and analyzed using ABI Prism SDS version 2.0.5 (Life
Technologies Corporation, Burlington, On.).
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Measurement of FA composition in plasma
phospholipids
Subjects arrived at the research center following an over-
night fast. FA composition of plasma phospholipids was
determined by gas chromatography. Venous blood was
drawn into EDTA tubes, and plasma was immediately
separated by centrifugation at 500 g for 6 min and stored at
-80 C for subsequent analyses. Plasma lipids were
extracted with chloroform:methanol (2:1, by volume)
according to a modified Folch method (Shaikh and Downar
1981). Total phospholipids were then isolated with iso-
propyl ether:acetic acid (96:4) by thin layer chromatogra-
phy (Lepage and Roy 1986). Isolated plasma phospholipids
were then methylated (Lepage and Roy 1986). FA profiles
were obtained after methylation in methanol/benzene 4:1
(v/v) (Lepage and Roy 1986) and capillary gas chroma-
tography using a temperature gradient on a HP5890 gas
chromatograph (Hewlett Packard, Toronto, Canada)
equipped with a HP-88 capillary column (100 m 9
0.25 mm i.d. 9 0.20 lm film thickness; Agilent Technol-
ogies, Palo Atto, CA) coupled with a flame ionization
detector (FID). Helium was used as carrier gas (split ratio
1:80). FA were identified according to their retention time,
using the following standard mixtures as a basis for com-
parison: the FAME 37 mix (Supelco Inc., Bellefonte, PA)
and the GLC-411 FA mix (NuChek Prep Inc, Elysian,
MN), as well as the following methylated FAs C22:5n-6
(Larodan AB, Malmo¨, Sweden) and C22:5n-3 (Supelco
Inc., Bellefonte, PA). Phospholipids FA profiles were
expressed as the relative percentage areas of total FAs. The
database and ontology of Chemical Entities of Biological
Interest (ChEBI) has been used to identify FAs herein.
Estimates of D5D and D6D activities were computed
using product-to-precursor ratios: (C20:4n-6, AA):(C20:3n-
6, dihomo-c-linolenic acid (DGLA)), and (C20:3n-6,
DGLA):(C18:2n-6, linoleic acid (LA)), respectively, as
previously described (Bokor et al. 2010). The index of
elongase activity was calculated using the (C22:4n-
6):(C20:4n-6, AA) ratio.
Statistical analysis
All genotype distributions were tested for any deviation
from Hardy–Weinberg equilibrium (HWE) using the
ALLELE procedure in S.A.S Genetics v9.3 (S.A.S Institute
Inc., Cary, North Carolina, USA). Significance testing for
linkage disequilibrium coefficient D was obtained using a
Chi-square test, likelihood ratio and Fisher’s exact test
(p B 0.01). All other statistical analyses were carried out
using S.A.S statistical software v9.3 (S.A.S Institute Inc.,
Cary, North Carolina, USA). Normal distribution was
evaluated using the box-plot, as well as skewness and
kurtosis ranges. When needed, variables non-normally
distributed were log10-transformed. A linear regression
using the stepwise bidirectional elimination approach was
used to assess which SNPs could explain part of the
enzyme activity’s variance where the effects of the SNPs,
age, sex, and BMI were included in the statistical model
and where the effect of baseline enzyme activity was added
(in post-supplementation only). The MIXED procedure
was used to test for the effects of the genotype, the sup-
plementation (effect of time) and the genotype 9 supple-
mentation interaction for each SNP on estimates of enzyme
activities when age, sex and BMI were included in the
model. The repeated statement was used to indicate the
within subjects (repeated) variables. Genotype groups were
assessed as three groups expressed as major allele homo-
zygotes, heterozygotes and minor allele homozygotes. For
some SNPs, heterozygotes and minor allele homozygotes
were grouped if the genotype frequency was under 5 %.
The statistical significance was defined as p B 0.05. Since
polymorphisms tested in complex diseases rarely account
for a large proportion of the variance, results are thus
presented before correction for multiple testing and using a
p B 0.05.
Results
Subjects’ characteristics pre- and post-supplementation are
presented in Table 1. Estimates of D5D activity increased by
25.7 ± 28.8 % (Mean ± SD, p \ 0.0001), whereas surro-
gate estimates of D6D activity decreased by 17.7 ± 18.2 %
(p \ 0.0001) after the supplementation. Index of elongase
activity decreased by 39.5 ± 27.9 % (p \ 0.0001) (Table 1).
Triglyceride, insulin, total-cholesterol and LDL-cholesterol
levels were inversely associated with D5D activity and pos-
itively associated with D6D activity after the supplementa-
tion (data not shown, p \ 0.008 for all). Moreover, a decrease
in plasma levels of n-6 FAs was observed: LA
(-9.85 ± 10.76 %, p \ 0.0001); AA (-11.20 ± 9.99 %,
p \ 0.0001); as well as a decrease in plasma levels of ALA
(-31.44 ± 50.44 %, p = 0.0002) following the interven-
tion. On the n-3 FAs side, an increase was observed for
plasma levels of EPA (?331.11 ± 214.74 %, p \ 0.0001)
and DHA (?46.31 ± 27.46 %, p \ 0.0001). The same pat-
tern was also observed for absolute quantities of FAs (lg/ml)
where similar rates of change were revealed as shown in
Table 1.
All SNPs were in HWE except rs7935946 (FADS) that
was not considered for further analyses. All selected SNPs
are presented in Table 2 and LD tables are presented in
Tables 3, 4, and 5. To validate the presence of associations
between surrogate estimates of enzyme activities involved
in the n-3 FA synthesis pathway with SNPs of the FADS
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gene cluster or ELOVL gene family, all SNPs were included
in a stepwise regression model adjusted for the effects of
age, sex and BMI. Prior to the n-3 FA supplementation,
three SNPs were associated with the estimates of D5D
activity: rs968567 (R2 = 13.83 %, p \ 0.0001), rs2845573
(R2 = 11.65 %, p \ 0.0001) and rs7394871 (R2 = 4.25 %,
p \ 0.0001), one SNP was associated with estimates of
D6D activity: rs968567 (R2 = 2.86 %, p = 0.01) and two
SNPs were associated with the index of elongase activity:
rs2281591 (R2 = 3.21 %, p = 0.008) and rs3798710
(R2 = 2.79 %, p = 0.01). To account for the 6-week sup-
plementation, the same statistical model was used with data
post-n-3 FA supplementation as the dependent variable,
adjusted for baseline data, age, sex and BMI. With the use
of the stepwise bidirectional selection method, five SNPs
were associated with the post-supplementation estimates of
D5D activity: rs174546 (R2 = 8.26 %, p \ 0.0001),
rs968567 (R2 = 2.47 %, p = 0.004), rs7935946
(R2 = 2.42 %, p = 0.004), rs2072114 (R2 = 2.92 %,
p = 0.001) and rs12807005 (R2 = 1.20 %, p = 0.04); one
SNP was associated with post-supplementation estimates of
D6D activity: rs12807005 (R2 = 0.92 %, p = 0.04); and
none of the SNPs were associated with the index of
elongase activity after an n-3 FA supplementation (data not
shown) (Tables 6, 7, 8).
In a MIXED model for repeated measures including the
effects of time (supplementation), genotype and the inter-
action (genotype 9 supplementation) adjusted for age, sex
and BMI, ten SNPs of the FADS gene cluster (rs174546,
rs2072114, rs2845573, rs174570, rs174579, rs174611,
rs174616, rs968567, rs174627 and rs174448) were asso-
ciated with estimates of D5D activity (p \ 0.04, for all).
Three SNPs were associated with surrogate estimates of
D6D activity (rs174546, rs175579 and rs968567, p \ 0.04,
for all), and one SNP was associated with the index of
elongase activity: rs2281591 (p = 0.01) (Tables 6, 7, 8).
Results in Tables 6, 7, and 8 were only provided for fre-
quent SNPs with MAFs[20 % and/or for significant gene–
diet interaction effects. Some gene–diet interaction effects
with SNPs within the FADS gene cluster or the ELOVL
gene family were found and could potentially modulate the
enzyme activities of desaturases and elongases following







Age (years) 30.8 ± 8.7
Weight (kg) 81.3 ± 13.9 81.6 ± 14.2 0.82
BMI (kg/m2) 27.8 ± 3.7 27.9 ± 3.8 0.81
Plasma desaturase activity
D5D (20:4n-6/20:3n-6) 3.57 ± 1.15 4.34 ± 1.25 25.71 ± 28.83 (n = 210) \0.0001
D6D (20:3n-6/18:2n-6) 0.17 ± 0.05 0.14 ± 0.04 -17.68 ± 18.15 (n = 210) \0.0001
Plasma elongase activity
ELOVL2 (22:4n-6/20:4n-6) 0.0318 ± 0.0064 0.0193 ± 0.0093 -39.52 ± 27.89 (n = 209) \0.0001
Omega-6 (% of total FAs)
Linoleic acid, C18:2n-6, LA 19.71 ± 2.08 17.69 ± 2.22 -9.85 ± 10.76 \0.0001
Arachidonic acid, C20:4n-6, AA 11.05 ± 1.74 9.74 ± 1.44 -11.20 ± 9.99 \0.0001
Omega-3 (% of total FAs)
Alpha-linolenic acid, C18:3n-3, ALA 0.18 ± 0.15 0.14 ± 0.12 -31.44 ± 50.44 0.0002
Eicosapentaenoic acid, C20:5n-3, EPA 1.12 ± 0.52 4.10 ± 1.28 331.11 ± 214.74 \0.0001
Docosahexaenoic acid, C22:6n-3, DHA 3.53 ± 0.77 5.03 ± 0.86 46.31 ± 27.46 \0.0001
Omega-6 (lg/ml)
Linoleic acid C18:2n-6, LA 227.26 ± 44.46 199.16 ± 45.38 -11.63 ± 15.82 \0.0001
Arachidonic acid, C20:4n-6, AA 128.14 ± 32.77 109.63 ± 27.03 -13.04 ± 14.26 \0.0001
Omega-3 (lg/ml)
Alpha-linolenic acid, C18:3n-3, ALA 2.22 ± 1.89 1.72 ± 1.52 -32.08 ± 51.42 \0.0001
Eicosapentaenoic acid, C20:5n-3, EPA 12.92 ± 6.41 46.15 ± 16.99 328.79 ± 227.51 \0.0001
Docosahexaenoic acid, C22:6n-3, DHA 40.97 ± 12.54 57.04 ± 16.05 43.55 ± 33.50 \0.0001
Measurements made prior to- and after a 6-week n-3 FA supplementation; values are mean ± SD
The rate of change (D) expressed as the relative variation of plasma FAs as a percentage (%) or absolute quantities (lg/ml) between the pre- and
post-n-3 PUFA period. Differences between the pre- and post-n-3 PUFA supplementation were tested using a pairwise Student’s t test
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the n-3 FA supplementation. Two gene–diet interactions
on D6D activities were found with SNPs of the FADS gene
cluster for rs174611 (p = 0.01) and rs174627 (p = 0.02)
after the n-3 FA supplementation, and two gene–diet
interactions on the elongase activity were also found with
SNPs of the ELOVL gene family for rs12195587
(p = 0.02) and rs4532436 (p = 0.05) (Fig. 2).
Discussion
In this study, we tested whether a 6-week supplementation
with high doses of n-3 FA above 3 g/day led to differences
in enzyme activities expressed as surrogate estimates of
D5D and D6D activities and index of elongase activity, as
well as if SNPs of genes encoding for these enzymes
modulate the enzyme activity following a 6-week n-3 FA
supplementation. To do so, 28 SNPs were selected from
five genes (FADS1, FADS2, FADS3, ELOVL2 and
ELOVL5) covering at least 85 % of the common genetic
variations.
In the present study, a decrease in plasma levels of n-6
FAs (LA, DGLA, AA and adrenic acid) was observed as
well as a decrease in plasma levels of ALA, an essential
n-3 FA that is also the precursor for the synthesis of EPA
and DHA. Subsequently, an increase in the estimate of
D5D activity and a decrease in the estimate of D6D
activity and the index of elongase activity were observed.
D5D activity was negatively associated with cardio-meta-
bolic risk factors, while D6D activity was positively
associated. Minor alleles of some SNPs in the FADS gene
cluster are associated with higher D6D activity and with
lower D5D activity in French Canadians while minor allele
of SNPs from the ELOVL gene family are associated with
higher elongase activity following a 6-week supplemen-
tation with 5 g/day of fish oil.
The endogenous synthesis of LC-PUFAs is made pos-
sible by concerted actions between elongases and desatu-
rases. Index of elongase activity has been much less
extensively studied in the context of CVD than desaturase
activity was, but Sethom et al. (2011) have shown that
elongase and D5D activities tended to decrease according
to the number of metabolic syndrome features in Tunisian
patients (Sethom et al. 2011). In the current study, we
observed a significant increase of D5D activity following
an n-3 FA supplementation meaning that the n-3 FA sup-
plementation may exert beneficial effects on CVD risk
factors thus potentially impacting on obesity and metabolic
syndrome features. A recent study suggested that fatty acid
elongase-5 (encoded by ELOVL5 gene) plays a key role in
regulating hepatic lipid and carbohydrate metabolism
(Wang et al. 2008). Fatty acid elongase-5 elongates c-
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which is converted to AA (C20:4n-6) by the D5D (FADS1)
in the n-6 metabolism (Moon et al. 2009; Qin et al. 2009).
There is a competition between ALA and C24:5n-3 (tet-
racosapentaenoic acid) for the D6D, which could lead to
decreased levels of DHA after certain intakes of dietary ALA
(Gregory et al. 2011). However, in the present study,
EPA ? DHA was given directly via fish oil supplements,
increasing considerably DHA intake and favoring the
incorporation of n-3 FA in plasma phospholipids at the
expense of the incorporation of n-6 s. Thus, we hypothesized
that the D6D (FADS2) is more likely to be used to convert
ALA in C18:4n-3 as shown by decreased ALA levels in
plasma phospholipids (Table 1). Gregory et al. (2011)also
observed a saturation of the second FA elongase-2 reaction
(DPA, C22:5n-3 ? C24:5n3) that could potentially explain
the accumulation of DPA when EPA is provided in the diet.
In the present study, plasma phospholipid EPA levels
increased by 330.0 ± 214.1 % after the 6-week supple-
mentation and DPA increased by 49.0 ± 36.8 % (Table 1).
Since D6D is the rate-limiting enzyme in the PUFA
metabolism (Sprecher 2002) and is not specific to a single
pathway, one could pretend that giving high doses of n-3
possibly activates the n-3 FA pathway and favors the
incorporation of n-3 FAs at the expense of the incorpora-
tion of n-6 FAs. Moreover, the use of D6D twice in the
conversion of LC-PUFAs suggests that this enzyme may
play a key regulatory role in the PUFA metabolism (Por-
tolesi et al. 2008).
In the present study, we found two gene–diet inter-
actions with SNPs from the FADS gene cluster and the
n-3 FA supplementation modulating surrogate estimates
of D6D activity where carriers of the minor allele had
the lowest activity. Warensjo et al. confirmed that
estimates of D5D activity are inversely related to
obesity and insulin resistance, whereas D6D activity
shows positive associations (Warensjo et al. 2009).
Increased estimates of D6D activities and decreased
estimates of D5D and elongase activities were also
associated with adverse profiles of several metabolic
risk factors in a group of free-living young Japanese
women (Murakami et al. 2008). After the 6-week n-3
FA supplementation, we observed an increase in the
estimates of D5D activity and a decrease in the esti-
mates of D6D activity meaning that n-3 FA supplements
may be beneficial in the prevention of obesity and
insulin resistance. SNPs within the FADS gene cluster
are believed to alter desaturase activity as shown in a
recent paper by Merino et al. (2011), especially
rs175547 (in high LD with rs174546, r2 = 1.0) thought
to be a causal SNP in the FADS gene cluster (Merino
et al. 2011). Herein, minor allele homozygotes of all
SNPs (or minor allele homozygotes ? heterozygotes for
SNPs included in the dominant model) that were asso-
ciated with estimates of D5D activity always exhibited
the lowest desaturase activity after the 6-week n-3 FA
supplementation, suggesting that they may be at higher
risk to develop obesity-related metabolic complications.
Previous studies have also reported associations
between SNPs within the FADS gene cluster and estimates
of desaturase activities (Bokor et al. 2010; Martinelli et al.
2008). Recently, Gillingham et al. (2013) have studied the
effects of diets enriched in flaxseed oil or high-oleic acid
canola oil and SNPs from FADS1-2 genes on plasma FAs
and found several SNPs associated with [U-13C]ALA
metabolism, a precise measure of desaturase activity. Al-
Hilal et al. (2013) have shown that genotypes of three SNPs
located in the FADS1/FADS2 gene cluster were strongly
associated with proportions of LC-PUFAs and desaturase
activities estimated in plasma and in erythrocytes. The
same research group has also shown that a higher
EPA ? DHA dosage reduced n-6 and increased n-3 LC-
PUFA proportions and that D5D desaturase activity
increased which is concomitant with results observed here
(Al-Hilal et al. 2013). In the present study, we have found
three significant gene–diet interactions after a 6-week n-3
FA supplementation. In addition, some SNPs were
Table 4 Linkage
disequilibrium (R2) of the
tagging SNPs within the
ELOVL2 gene
rs4532436 rs12195587 rs2281591 rs911196 rs976081 rs13204015
rs4532436 0.169 0.372 0.301 0.237 0.061
rs12195587 0.169 0.063 0.051 0.056 0.297
rs2281591 0.372 0.063 0.08 0.088 0.023
rs911196 0.301 0.051 0.08 0.071 0.019
rs976081 0.237 0.056 0.088 0.071 0.001
rs13204015 0.061 0.297 0.023 0.019 0.001
Table 5 Linkage disequilibrium (R2) of the tagging SNPs within the
ELOVL5 gene cluster
rs2073040 rs2294852 rs9370194 rs209492
rs2073040 0.576 0.737 0.153
rs2294852 0.576 0.423 0.067
rs9370194 0.737 0.423 0.02
rs209492 0.153 0.067 0.02
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associated with indexes of desaturase or elongase activities
independently of the supplementation.
Strengths and limitations
Indexes of desaturase and elongase activities were esti-
mated using product-to-precursor ratios as surrogate
markers of desaturase or elongase activities, because
direct measures were not possible. The quantification of
the GLA FA was not feasible resulting from low pro-
portions of that specific FA in plasma phospholipids.
Although there is an elongation step comprise in the
(20:3n-6)/(18:2n-6) ratio, it should be noted that this is not
considered as the rate-limiting step in the n-6 Fas syn-
thesis. Consequently, the (20:3n-6)/(18:2n-6) ratio was
considered as good estimates and was used to assess the
estimate of D6D activity (Bokor et al. 2010; Krachler
et al. 2008; Warensjo et al. 2008). Indexes of desaturase
and elongase activities depend not only on enzyme
activities, but also on PUFA intake.
Conclusions
In summary, a 6-week fish oil supplementation decreased
plasma levels of n-6 and increased plasma n-3 FA levels
impacting desaturase and elongase activities. Genetic pre-
dispositions on genes coding for these enzymes may lead to
more or less LC-PUFA conversion depending on the
genotype. Some SNPs of the FADS gene cluster and the
ELOVL gene family may play an important role in the
enzyme activity of desaturases and elongases, suggesting
that a supplementation with n-3 FA may affect PUFA
metabolism.
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Fig. 2 Gene–diet interaction effects modulating indexes of enzyme activities after an n-3 fatty acid supplementation
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